Two New Health Institutions Join the CATALIS FAST TRACK Evaluation Service
The FAST TRACK Evaluation Service continues to grow, and we are proud to announce that two new Health and Social Services Institutions (HSSIs) will soon be offering this Service. The CISSS de la Montérégie-Est and the CIUSSS de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ) are one of 21 institutions that have been participating in this initiative to fast track the start of clinical trials in Quebec since 2022.
Each new HSSIs that joins the FAST TRACK Evaluation Service strengthens Quebec’s capacity for a faster delivery of clinical trials to the entire population. By expanding this network, we are increasing opportunities for patients across Quebec to gain earlier access to innovative research options. These strategic partnerships strengthen Quebec’s position as a leader in health innovation, while fast tracking the evaluation and development of new medical approaches for the population.
“We are pleased to join the CATALIS FAST TRACK Evaluation Service, which is celebrating four years of success. Clinical research carried out in the region is a catalyst for the development of relevant, high-quality care close to where people live. It also acts as a growth driver for our Centre hospitalier affilié universitaire régional (CHAUR – Regional University Affiliated Hospital Centre).” – Renée Proulx, Ph. D., Executive Director of University Education, Research and Innovation, Department of university education, research and innovation Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ)
“Our institution’s participation in the CATALIS FAST TRACK Evaluation Service is a key driver in accelerating the start of clinical trials in our institution. By facilitating collaboration among partners and optimizing evaluation processes, this initiative will increase research opportunities and provide the people of Montérégie-Est with faster access to innovative therapeutic approaches.” – Sophie Poirier, Director of Education, Research and Innovation, CISSS de la Montérégie-Est
Partner HSSIs: Pillars of the Success of the FAST TRACK Evaluation Service
To date, fifteen (15) major global pharmaceutical companies have used the CATALIS FAST TRACK Evaluation Service and have benefitted from a total of 277 institutional authorizations obtained in a median time of 10 weeks. This provincial administrative efficiency has enabled many health institutions in Quebec to rank among the first sites activated worldwide, thus allowing for faster start of trials and optimized recruitment of participants.
Discover the performances of the FAST TRACK Evaluation Service
CATALIS would like to thank its member pharmaceutical institutions and companies for their expertise and commitment to fast tracking the development of innovative treatments. Together, we continue to improve the clinical research environment for the well-being of patients in Quebec.
If you have any questions about CATALIS or the FAST TRACK Evaluation Service, please contact us at info@catalisquebec.com.
